)
)
InspireMD Inc Investor Relations Material
Latest events
Q3 2024
InspireMD Inc
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from InspireMD Inc
Access all reports
InspireMD Inc. is a medical device company specializing in the development and commercialization of its proprietary MicroNet stent platform technology. This technology is primarily aimed at addressing complex vascular and coronary diseases. The company's key products include the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard prime embolic protection system, which are designed for carotid artery applications and coronary interventions, respectively. InspireMD's strategy involves selling its medical devices through local distribution partners, extending its reach across multiple regions. The company was established in 2005 and is headquartered in Tel Aviv-Yafo, Israel. Its shares are listed on the NASDAQ.
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
NSPR
Country
🇺🇸 United States